- Inicio
- Proyectos y Estudios
- ENSAYO DE FASE IIIB, MULTICENTRICO, MULTINACIONAL, ALEATORIZADO, DOBLE-CIEGO, CON CONTROL PLACEBO Y EN GRUPOS PARALELOS, PARA DETERMINAR LA EFICACIA Y SEGURIDAD DE ORG32818 (REGIMEN DE 28 DIAS) FRENTE A TRISEQUENS DURTANTE SEIS MESES, EN MUJERES PERI- YPOST-MENOPAUSICAS CON SOFOCOS.
ENSAYO DE FASE IIIB, MULTICENTRICO, MULTINACIONAL, ALEATORIZADO, DOBLE-CIEGO, CON CONTROL PLACEBO Y EN GRUPOS PARALELOS, PARA DETERMINAR LA EFICACIA Y SEGURIDAD DE ORG32818 (REGIMEN DE 28 DIAS) FRENTE A TRISEQUENS DURTANTE SEIS MESES, EN MUJERES PERI- YPOST-MENOPAUSICAS CON SOFOCOS.
Datos básicos
- Código:
- 36617
- Protocolo:
- 36617
- EUDRACT:
- NO PROCEDE
- NCT:
- Centro:
- Dotación:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
NV ORGANON
Resultados del Ensayo Clínico
Effect of BoNT/A in the Surface Electromyographic Characteristics of the Pelvic Floor Muscles for the Treatment of Chronic Pelvic Pain
Albaladejo-Belmonte, M; (...); Garcia-Casado, J
Article. 10.3390/s21144668. 2021
Experience with nutraceutical supplements in the treatment of pelvic pain in gynaecology: case reports.
Case Reports. 10.7573/dic.2021-10-8. 2022
Gender dysphoria: laparoscopic sigmoid vaginoplasty. another utility of IndoCyanine Green (ICG).
Flor-Lorente, Blas; (...); Simon-Sanz, Eduardo Antonio
Article. 10.1111/codi.15952. 2021
Pelvic floor muscle electrical coupling in chronic pelvic pain: Insights into pathophysiology and botulinum toxin treatment effects.
Albaladejo-Belmonte M; (...); Garcia-Casado J
Article. 10.1016/j.jelekin.2024.102940. 2024
Prevalence and impact of pelvic floor dysfunctions on quality of life in women 5-10 years after their first vaginal or caesarian delivery.
Gonzalez-Timoneda, Alba; (...); Nohales Alfonso, Francisco
Article. 10.1016/j.heliyon.2025.e42018. 2025
Treatment of Dyspareunia with Botulinum Neurotoxin Type A: Clinical Improvement and Influence of Patients' Characteristics
Tarazona-Motes, M; (...); Alberola-Rubio, J
Article. 10.3390/ijerph18168783. 2021
Treatment of Vestibulodynia with Submucosal Injections of IncobotulinumtoxinA into Targeted Painful Points: An Open-Label Exploratory Study.
Villa-Muñoz P; (...); Garcia-Casado J
Article. 10.3390/toxins15080476. 2023
Vulvodynia-It Is Time to Accept a New Understanding from a Neurobiological Perspective
Torres-Cueco R, Nohales-Alfonso F
Review. 10.3390/ijerph18126639. 2021